Quantitative Research of 11C-CFT and 18F-FDG PET in Parkinson's Disease: A Pilot Study With NeuroQ Software

Xun Sun; Fang Liu; Qingyao Liu; Yongkang Gai; Weiwei Ruan; Dilani Neranjana Wimalarathne; Fan Hu; Xubo Tan; Xiaoli Lan

doi:10.3389/fnins.2019.00299

Quantitative Research of ¹¹C-CFT and ¹⁸F-FDG PET in Parkinson's Disease: A Pilot Study With NeuroQ Software

Front Neurosci. 2019 Apr 5:13:299. doi: 10.3389/fnins.2019.00299. eCollection 2019.

Authors

Xun Sun^{1

2}, Fang Liu^{1

2}, Qingyao Liu^{1

2}, Yongkang Gai^{1

2}, Weiwei Ruan^{1

2}, Dilani Neranjana Wimalarathne^{1

2}, Fan Hu^{1

2}, Xubo Tan^{1

2}, Xiaoli Lan^{1

2}

Affiliations

¹ Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
² Hubei Key Laboratory of Molecular Imaging, Wuhan, China.

Abstract

Dopamine transporter (DAT) and glucose metabolism imaging have been applied in the diagnosis of Parkinson's disease (PD). We explored the possibility of evaluating for PD with NeuroQ software by analyzing ¹¹C-2β-carbomethoxy-3β-(4-fluorophenyl) tropane (¹¹C-CFT) and ¹⁸F-FDG PET/CT. We retrospectively analyzed brain ¹¹C-CFT and ¹⁸F-FDG PET/CT of 38 patients with parkinsonism, including 20 with PD, 10 with multiple system atrophy (MSA) and 8 with essential tremor (ET), and compared them with the PET/CT of 11 normal healthy controls (NC). PD patients were divided into mild and moderate-severe grade according to the Hoehn-Yahr (H&Y) scale. The ¹¹C-CFT uptake in the caudate nuclei (CN) and putamen (Pu) normalized with cerebellum (CN/Cb and Pu/Cb) were obtained with a manual method and NeuroQ software, and their diagnostic performance was compared.¹⁸F-FDG uptake of specific regions was also obtained with NeuroQ, and the enhancement effect for the differential diagnosis was evaluated. There was significant agreement between the manual method and the NeuroQ method for ¹¹C-CFT uptake by CN (r² = 0.680) and Pu (r² = 0.770). ¹¹C-CFT uptake by CN and Pu in PD and MSA patients was significantly lower compared to NC and ET patients. The cutoffs of CN/Cb and Pu/Cb for the distinction between PD and NC were 1.71 and 2.20, respectively. No difference in uptake ratios occurred between PD and MSA. ¹⁸F-FDG uptake by the pons and cerebellum in the MSA group was markedly decreased. It was highly accurate in distinguishing between PD and MSA when combined with analysis of ¹¹C-CFT uptake. Pu/Cb decreased significantly in mild grade PD compared to NC group (1.92 ± 0.33 vs. 2.82 ± 0.43); however no statistically significant decrease in CN/Cb was observed until moderate-severe grade PD (1.43 ± 0.11 vs. 2.23 ± 0.36). In early asymmetric PD, a statistically significant difference could be seen with Pu/Cb between the symptomatic and asymptomatic side (2.17 ± 0.30 vs. 1.95 ± 0.22). ¹¹C-CFT and ¹⁸F-FDG PET/CT can be analyzed quantitatively with NeuroQ software, which provides an accurate method for the diagnosis and severity evaluation of PD.

Keywords: 11C-CFT; 18F-FDG; NeuroQ; PET; Parkinson’s disease; diagnosis.